Tuesday, March 5, 2019

Erasca Raises $64M For Oncology Drug Development Using AI

San Diego-based Erasca, a company which is using artificial intelligence to drive the discovery and development of new oncology drugs to help cure cancer, has raised $64M in a Series A funding, the company said this morning. The funding--which included both its Series A and an extension--came from ARCH Venture Partners, Andreessen Horowitz, Reneo Capital,

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---